MedTrace Logo

rTMS Treatment in Vascular Parkinsonism

NCT03720691 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2018-10-30

No results posted yet for this study

Summary

Vascular parkinsonism (VP), parkinsonism resulting from ischemic cerebrovascular disease, was suggested in 1929. The main features are wide-based gait, postural instability, and falls, which make patients with VP frustrated. Currently, the treatment is challenging.

Transcranial magnetic stiumation is a noninvasive procedure using electromagnetic induction to stimulate brain, and repetitive transcranial magnetic stiumation (rTMS) can selectively change brain activity to enhance desired effects. The aim of this study is to explore the therapeutic effect of rTMS for the VP.

Conditions

  • Vascular Parkinsonism

Interventions

DEVICE

Real rTMS Supplementary motor area

There will be a series of four rTMS blocks separated by 10 minutes. Each block will consist of 15 to 25 pulse trains of 1-second duration at 25 Hz, with an intertrain interval of 10 seconds.

DEVICE

Sham rTMS Supplementary motor area

There will be no real brain stimulation in Sham rTMS, and participant will be blinded.

Sponsors & Collaborators

  • Dongtan Sacred Heart Hospital

    collaborator OTHER

  • Inje University

    lead OTHER

Principal Investigators

  • Sang Jin Kim, MD, PhD · Inje Unversity, Busan Paik Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-31
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03720691 on ClinicalTrials.gov